Genetic Testing in Primary Care: What Your DNA Says About Your Health
Part of the Kosmos proactive care model
Modern genetic testing can identify pharmacogenomic patterns (how your body metabolizes common medications) and hereditary disease risk (cardiovascular, several cancers, specific neurological conditions) at a level that lets us personalize prevention years earlier than traditional risk assessment. Kosmos members in the Optimal Care program are tested every three years, and we interpret the results in the context of your full clinical picture, not in isolation.
Why this matters
Genetics adds a layer most primary care never reaches: not a horoscope, but a set of specific, actionable signals. Two are most useful. Pharmacogenomics tells us how you metabolize common medications, which explains why a standard dose of a statin, an antidepressant, or a blood thinner works cleanly for one person and causes side effects or does nothing for another. Knowing that in advance spares you much of the trial and error.
The second is hereditary risk for conditions like certain cancers and cardiovascular disease, where carrying a known variant changes how early and how often we screen. A result here can be the difference between catching something at a curable stage and finding it late.
For members who feel nervous about testing, the framing that helps is this: we are not reading your whole future. We are checking a defined list of variants that have clear medical actions attached, and we go through every result with you in person and in context.
What Kosmos does in this focus area
What we measure and track
- Genetic testing every three years through a clinically validated lab partner
- Pharmacogenomic analysis to predict medication response and dosing
- Hereditary risk screening for cardiovascular, cancer, and select neurological conditions
- Interpretation in the context of family history and current clinical data
What we look for
A genetic result is a starting point, not a verdict, so we read it alongside your family history and current health rather than on its own. We sort findings into what is actionable now and what is worth noting for later. A pharmacogenomic result might change a medication or a dose immediately. A hereditary risk variant might change a screening schedule, prompt earlier imaging, or simply be something we keep an eye on.
When a result carries real weight, especially a high-penetrance cancer or cardiac variant, we bring in a genetic counselor or the relevant specialist so you get expert interpretation and, where it matters, guidance for family members who may share the variant. Throughout, your physician keeps the full picture and turns the genetics into a concrete plan rather than a printout you are left to decode.
Who this is most relevant for
- Anyone with a family history of cancer, heart disease, or hereditary conditions
- Members starting new medications who want to predict response and side effects
- Patients planning major life decisions where health risk is a factor
- Members who want prevention strategy tailored to their actual genetic profile
FAQ
Common questions.
- Different category. Consumer kits like 23andMe give ancestry and a limited set of variants. Clinical genetic testing through Kosmos covers actionable pharmacogenomic and hereditary risk variants at the level of evidence needed for medical decisions. We can interpret consumer results, but the clinical test is what we order.
- Risk is not destiny. A high-risk result means we screen more proactively, intervene earlier, and coordinate with the right specialists. For some conditions it changes nothing in your daily life; for others it can prompt earlier imaging or surveillance. We walk through every result with you in person.
- Almost never a certainty. For most variants we test, risk is a probability shaped by lifestyle, environment, and other genes, not a fixed outcome. A higher-risk result usually just means we screen earlier and more often and intervene sooner, which is the whole point of knowing. A small number of high-penetrance variants carry stronger odds, and those we interpret carefully with a genetic counselor. Knowing your risk is what lets you act on it.
Speak with our physicians for 30 minutes.
An unhurried conversation about your health and how Kosmos can help. No obligation, no pressure.